These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10507379)

  • 21. Efficacy of levetiracetam compared with phenytoin in prevention of seizures in brain injured patients: A meta-analysis.
    Zhao L; Wu YP; Qi JL; Liu YQ; Zhang K; Li WL
    Medicine (Baltimore); 2018 Nov; 97(48):e13247. PubMed ID: 30508910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiepileptic prophylaxis following severe traumatic brain injury within a military cohort.
    Cranley MR; Craner M; McGilloway E
    J R Army Med Corps; 2016 Apr; 162(2):109-14. PubMed ID: 25712562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.
    Kaushal S; Rani A; Chopra SC; Singh G
    Neurol India; 2006 Jun; 54(2):157-60. PubMed ID: 16804259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
    Chaari A; Mohamed AS; Abdelhakim K; Kauts V; Casey WF
    Int J Clin Pharm; 2017 Oct; 39(5):998-1003. PubMed ID: 28780739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management.
    Wilson CD; Burks JD; Rodgers RB; Evans RM; Bakare AA; Safavi-Abbasi S
    World Neurosurg; 2018 Feb; 110():e901-e906. PubMed ID: 29196247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical look at phenytoin use for early post-traumatic seizure prophylaxis.
    Debenham S; Sabit B; Saluja RS; Lamoureux J; Bajsarowicz P; Maleki M; Marcoux J
    Can J Neurol Sci; 2011 Nov; 38(6):896-901. PubMed ID: 22030429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.
    Temkin NR; Dikmen SS; Wilensky AJ; Keihm J; Chabal S; Winn HR
    N Engl J Med; 1990 Aug; 323(8):497-502. PubMed ID: 2115976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury.
    Brophy GM; Tesoro EP; Schrote GL; Garnett WR
    Pharmacotherapy; 2002 Feb; 22(2):251-5. PubMed ID: 11837562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.
    Jones KE; Puccio AM; Harshman KJ; Falcione B; Benedict N; Jankowitz BT; Stippler M; Fischer M; Sauber-Schatz EK; Fabio A; Darby JM; Okonkwo DO
    Neurosurg Focus; 2008 Oct; 25(4):E3. PubMed ID: 18828701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: phenytoin use and efficacy in the ED.
    Gallop K
    Emerg Med Australas; 2010 Apr; 22(2):108-18. PubMed ID: 20534046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
    Pieracci FM; Moore EE; Beauchamp K; Tebockhorst S; Barnett CC; Bensard DD; Burlew CC; Biffl WL; Stoval RT; Johnson JL
    J Trauma Acute Care Surg; 2012 Jan; 72(1):276-81. PubMed ID: 22310136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of head injury. Posttraumatic seizures.
    Temkin NR; Dikmen SS; Winn HR
    Neurosurg Clin N Am; 1991 Apr; 2(2):425-35. PubMed ID: 1821751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium.
    Singh G; Kaushal S; Gupta M; Chander Chopra S
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):331-3. PubMed ID: 14742623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage.
    Chumnanvej S; Dunn IF; Kim DH
    Neurosurgery; 2007 Jan; 60(1):99-102; discussion 102-3. PubMed ID: 17228257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMPACT syndrome.
    Bilgili SG; Calka O; Karadag AS; Burakgazi AZ
    Cutan Ocul Toxicol; 2011 Dec; 30(4):328-30. PubMed ID: 21675930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial.
    Ellis AJ; Wendon JA; Williams R
    Hepatology; 2000 Sep; 32(3):536-41. PubMed ID: 10960446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy Of Phenytoin In Prevention Of Early Posttraumatic Seizures.
    Gul N; Khan SA; Khattak HA; Muhammad G; Khan AA; Khan I; Aurangzeb A
    J Ayub Med Coll Abbottabad; 2019; 31(2):237-241. PubMed ID: 31094124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse cognitive effects of phenytoin in severe brain injury: a case report.
    Pinder C; Young C
    Brain Inj; 2011; 25(6):634-7. PubMed ID: 21534742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic anticonvulsants in patients with brain tumour.
    Forsyth PA; Weaver S; Fulton D; Brasher PM; Sutherland G; Stewart D; Hagen NA; Barnes P; Cairncross JG; DeAngelis LM
    Can J Neurol Sci; 2003 May; 30(2):106-12. PubMed ID: 12774949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.